Genmab A/S (NASDAQ:GMAB) Receives Average Recommendation of

Genmab A/S (NASDAQ:GMAB – Get Free Report) has been given a consensus rating of “Hold” by the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have issued a buy recommendation on […]

Related Keywords

Denmark , , Jpmorgan Chase Co , Advisor Group , York Mellon Corp , Dimensional Fund Advisors , Genmabas Company Profile , Citigroup , Blackrock Inc , Morgan Stanley , Get Free Report , Marketbeat Ratings , Truist Financial , New York Mellon Corp , Fund Advisors , Get Free , Genmaba S , Nasdaq Gmab , Gmab , Medical , Ratings , Consensus ,